Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update

Authors

Sherif A. Rezk, UCI Medical Center
Xiaohui Zhao, UCI Medical Center
Lawrence M. Weiss, UCI Medical Center

Abstract

Epstein-Barr virus (EBV) has been linked to many human neoplasms including hematopoietic, epithelial, and mesenchymal tumors. Since our original review of EBV-associated lymphoproliferative disorders in 2007, many advances and developments have been reported. In this review, we will examine the recent advances in EBV-associated lymphoid/histiocytic proliferations, dividing them into reactive, B cell, T/NK cell, immunodeficiency-related, and histiocytic/dendritic cell proliferations.

Publication Title

Human Pathology

Recommended Citation

Rezk, S., Zhao, X., & Weiss, L. (2018). Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update. Human Pathology, 79, 18-41. https://doi.org/10.1016/j.humpath.2018.05.020